These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 29753086)

  • 21. Innovations driving biomarker evaluation and use.
    Wagner JA
    Biomark Med; 2010 Dec; 4(6):779-81. PubMed ID: 21133694
    [No Abstract]   [Full Text] [Related]  

  • 22. Recent technological developments in proteomics shed new light on translational research on diabetic microangiopathy.
    Ma Y; Yang C; Tao Y; Zhou H; Wang Y
    FEBS J; 2013 Nov; 280(22):5668-81. PubMed ID: 23763694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent advances in quantitative and chemical proteomics for autophagy studies.
    Wong YK; Zhang J; Hua ZC; Lin Q; Shen HM; Wang J
    Autophagy; 2017 Sep; 13(9):1472-1486. PubMed ID: 28820289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new light of proteomics in cell biology and toxicology.
    Qiao T; Wang X
    Cell Biol Toxicol; 2019 Aug; 35(4):289-291. PubMed ID: 31428956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteomics approaches in the quest of kidney disease biomarkers.
    Frantzi M; Bitsika V; Charonis A; Vlahou A
    Prilozi; 2011; 32(2):33-51. PubMed ID: 22286613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current and Future Roles of Artificial Intelligence in Medicinal Chemistry Synthesis.
    Struble TJ; Alvarez JC; Brown SP; Chytil M; Cisar J; DesJarlais RL; Engkvist O; Frank SA; Greve DR; Griffin DJ; Hou X; Johannes JW; Kreatsoulas C; Lahue B; Mathea M; Mogk G; Nicolaou CA; Palmer AD; Price DJ; Robinson RI; Salentin S; Xing L; Jaakkola T; Green WH; Barzilay R; Coley CW; Jensen KF
    J Med Chem; 2020 Aug; 63(16):8667-8682. PubMed ID: 32243158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The present and future of project management in pharmaceutical R&D.
    Schuhmacher A; Gassmann O; Hinder M; Kuss M
    Drug Discov Today; 2021 Jan; 26(1):1-4. PubMed ID: 32745523
    [No Abstract]   [Full Text] [Related]  

  • 28. Proteomics: in pursuit of effective traumatic brain injury therapeutics.
    Lizhnyak PN; Ottens AK
    Expert Rev Proteomics; 2015 Feb; 12(1):75-82. PubMed ID: 25603864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The contribution of mass spectrometry-based proteomics to understanding epigenetics.
    Noberini R; Sigismondo G; Bonaldi T
    Epigenomics; 2016 Mar; 8(3):429-45. PubMed ID: 26606673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A review of current proteomics technologies with a survey on their widespread use in reproductive biology investigations.
    Wright PC; Noirel J; Ow SY; Fazeli A
    Theriogenology; 2012 Mar; 77(4):738-765.e52. PubMed ID: 22325247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Next Era: Deep Learning in Pharmaceutical Research.
    Ekins S
    Pharm Res; 2016 Nov; 33(11):2594-603. PubMed ID: 27599991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemical proteomic strategies for the discovery and development of anticancer drugs.
    Liu Y; Guo M
    Proteomics; 2014 Mar; 14(4-5):399-411. PubMed ID: 24323546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proteomics in Neural Crest Cell Research.
    McCarthy P; Schwarz Q
    Methods Mol Biol; 2019; 1976():153-165. PubMed ID: 30977072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of chemical biology in target identification and drug discovery.
    Zhu Y; Xiao T; Lei S; Zhou F; Wang MW
    Arch Pharm Res; 2015 Sep; 38(9):1642-50. PubMed ID: 26242900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unraveling the histone's potential: a proteomics perspective.
    Brumbaugh J; Phanstiel D; Coon JJ
    Epigenetics; 2008 Sep; 3(5):254-7. PubMed ID: 18849650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single-cell analysis tools for drug discovery and development.
    Heath JR; Ribas A; Mischel PS
    Nat Rev Drug Discov; 2016 Mar; 15(3):204-16. PubMed ID: 26669673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contribution of proteomics of Leishmania spp. to the understanding of differentiation, drug resistance mechanisms, vaccine and drug development.
    Paape D; Aebischer T
    J Proteomics; 2011 Aug; 74(9):1614-24. PubMed ID: 21621022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Challenge to the Development of Molecular Targeted Therapy against a Novel Target Candidate Identified by Antibody Proteomics Technology].
    Nagano K
    Yakugaku Zasshi; 2016; 136(2):145-9. PubMed ID: 26831784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proteomics in Drug Development: The Dawn of a New Era?
    Frantzi M; Latosinska A; Mischak H
    Proteomics Clin Appl; 2019 Mar; 13(2):e1800087. PubMed ID: 30724014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Development of a Drug Discovery Method Targeted to Stromal Tissue].
    Kamada H
    Yakugaku Zasshi; 2016; 136(3):435-41. PubMed ID: 26935083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.